Related Experiment Video
Updated: Jun 6, 2026
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
A prospective pilot study evaluating the 'cardiac decompensation score' in the setting of intraaortic balloon
Peter A Lewis1, Harry Bartlett, Shane Townsend
1Queensland University of Technology, Brisbane, Australia. p.lewis@qut.edu.au
Insights
The cardiac decompensation score accurately identifies worsening heart function in patients receiving intraaortic balloon counterpulsation (IABP). Higher scores indicate poor outcomes, suggesting the score aids in early intervention for improved IABP therapy.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Device Technology
Background:
- Intraaortic balloon counterpulsation (IABP) is a critical intervention for patients with severe cardiac compromise.
- Monitoring patient response to IABP therapy is essential for optimizing outcomes.
- Existing methods may not always provide timely or accurate assessments of cardiac decompensation during IABP support.
Purpose of the Study:
- To evaluate the efficacy of the 'cardiac decompensation score' in identifying cardiac decompensation in patients managed with IABP.
- To determine if the score can predict patient outcomes during IABP therapy.
Main Methods:
- A pilot study utilizing a one-group, posttest-only design.
- Observations were collected from 23 consecutive intraaortic balloon counterpulsation (IABP) recipients in an intensive care unit.
- The 'cardiac decompensation score' was calculated and analyzed in relation to patient survival and treatment escalation.
Main Results:
- Non-survivors (17.4%) consistently exhibited rising scores, with final scores of 25 or higher.
- Survivors achieved a maximum score of 15.
- Scores generally decreased following therapy escalation (p=0.016), indicating a positive response to interventions.
Conclusions:
- The 'cardiac decompensation score' appears to accurately reflect individual patient cardiac function changes during IABP therapy.
- Integrating this score with IABP management may enable earlier detection of functional decline.
- This could potentially lead to improved patient outcomes and enhanced IABP effectiveness.
Abstract:
The study objective was to determine whether the 'cardiac decompensation score' could identify cardiac decompensation in a patient with existing cardiac compromise managed with intraaortic balloon counterpulsation (IABP). A one-group, posttest-only design was utilised to collect observations in 2003 from IABP recipients treated in the intensive care unit of a 450 bed Australian, government funded, public, cardiothoracic, tertiary referral hospital. Twenty-three consecutive IABP recipients were enrolled, four of whom died in ICU (17.4%). All non-survivors exhibited primarily rising scores over the observation period (p<0.001) and had final scores of 25 or higher. In contrast, the maximum score obtained by a survivor at any time was 15. Regardless of survival, scores for the 23 participants were generally decreasing immediately following therapy escalation (p=0.016). Further reflecting these changes in patient support, there was also a trend for scores to move from rising to falling at such treatment escalations (p=0.024). This pilot study indicates the 'cardiac decompensation score' to accurately represent changes in heart function specific to an individual patient. Use of the score in conjunction with IABP may lead to earlier identification of changes occurring in a patient's cardiac function and thus facilitate improved IABP outcomes.
